Страница клинических исследований Nct
Clinical Trial Results:
An open-label extension study to study 100185, to evaluate long-term safety, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome.
| Summary | |
EudraCT number | 2004-000930-35 |
Trial protocol | IT BE |
Global completion date | 29 Sep 2010 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 16 Feb 2016 |
First version publication date | 13 Nov 2014 |
Other versions | |
Summary report(s) | 100901-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.